infliximab-dyyb
infliximab-dyyb is listed in the FDA National Drug Code directory with 12 NDC codes, marketed under brand names including ZYMFENTRA, INFLECTRA. Available dosage forms: kit, injection, powder, lyophilized, for solution, injection, solution, injection.
Drug details
- Generic Name
- infliximab-dyyb
- Brand Names
- ZYMFENTRA, INFLECTRA
- Application Number
- BLA761358
- Sponsor
- CELLTRION USA Inc.
- NDC Codes
- 12
- Dosage Forms
- KIT, INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, INJECTION, SOLUTION, INJECTION
- Routes
- INTRAVENOUS, SUBCUTANEOUS
- Active Ingredients
- INFLIXIMAB, INFLIXIMAB-DYYB
Indications and Usage
1 INDICATIONS AND USAGE ZYMFENTRA is a tumor necrosis factor (TNF) blocker indicated in adults for maintenance treatment of: moderately to severely active ulcerative colitis following treatment with an infliximab product administered intravenously. ( 1 ) moderately to severely active Crohn’s disease following with an infliximab products administered intraneously. ( 1 ) ZYMFENTRA is indicated in adults for maintenance treatment of: moderately to severely active ulcerative colitis following treatment with an infliximab product administered intravenously. moderately to severely active Crohn's disease following treatment with an infliximab product administered intravetnously.